R.G. Dale

596 total citations
16 papers, 470 citations indexed

About

R.G. Dale is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, R.G. Dale has authored 16 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in R.G. Dale's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Advanced Radiotherapy Techniques (3 papers). R.G. Dale is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (3 papers) and Advanced Radiotherapy Techniques (3 papers). R.G. Dale collaborates with scholars based in United Kingdom, United States and China. R.G. Dale's co-authors include RHJ Begent, Rong Wang, Liu Cm, Pei-Chieh Tien, C-W Liu, Richard J. Epstein, I. W. F. Hanham, Bleddyn Jones, F Searle and JA Ledermann and has published in prestigious journals such as British Journal of Cancer, European Journal of Cancer and Radiotherapy and Oncology.

In The Last Decade

R.G. Dale

15 papers receiving 452 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
R.G. Dale United Kingdom 10 223 205 81 71 67 16 470
D. Violot France 11 87 0.4× 124 0.6× 39 0.5× 71 1.0× 108 1.6× 15 352
T Egeland Norway 14 219 1.0× 91 0.4× 43 0.5× 40 0.6× 95 1.4× 18 551
María A. Saornil Spain 18 223 1.0× 207 1.0× 18 0.2× 44 0.6× 152 2.3× 55 777
JD Down Netherlands 11 140 0.6× 129 0.6× 37 0.5× 69 1.0× 108 1.6× 16 501
Alessia Bertolotti Italy 14 91 0.4× 178 0.9× 30 0.4× 140 2.0× 150 2.2× 38 517
Kai Eichhorn Germany 7 172 0.8× 121 0.6× 14 0.2× 151 2.1× 73 1.1× 13 447
Chang Shu Wang Canada 12 47 0.2× 139 0.7× 39 0.5× 173 2.4× 241 3.6× 15 565
Jennifer L. Wike United States 8 380 1.7× 229 1.1× 12 0.1× 164 2.3× 188 2.8× 8 655
C. Maschi France 15 141 0.6× 83 0.4× 25 0.3× 112 1.6× 201 3.0× 47 661
Jay Boyle United States 10 70 0.3× 179 0.9× 59 0.7× 248 3.5× 190 2.8× 22 735

Countries citing papers authored by R.G. Dale

Since Specialization
Citations

This map shows the geographic impact of R.G. Dale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R.G. Dale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R.G. Dale more than expected).

Fields of papers citing papers by R.G. Dale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R.G. Dale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R.G. Dale. The network helps show where R.G. Dale may publish in the future.

Co-authorship network of co-authors of R.G. Dale

This figure shows the co-authorship network connecting the top 25 collaborators of R.G. Dale. A scholar is included among the top collaborators of R.G. Dale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R.G. Dale. R.G. Dale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Miller, Mayumi F., Derek Gildea, Gennady Margolin, et al.. (2025). In vivo profiling of the endothelium using ‘AngioTag’ zebrafish. Angiogenesis. 28(3). 40–40.
2.
Jones, Bleddyn & R.G. Dale. (2018). The evolution of practical radiobiological modelling. British Journal of Radiology. 92(1093). 20180097–20180097. 26 indexed citations
3.
Cm, Liu, Zhuo Yang, C-W Liu, et al.. (2007). Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice. Gene Therapy. 15(3). 155–160. 77 indexed citations
4.
Cm, Liu, Yang Zhang, C-W Liu, et al.. (2007). Effect of RNA oligonucleotide targeting Foxo-1 on muscle growth in normal and cancer cachexia mice. Cancer Gene Therapy. 14(12). 945–952. 63 indexed citations
5.
Bottaro, Martim, et al.. (2002). SKINFOLD METHOD VS DUAL-ENERGY X-RAY ABSORPTIOMETRY TO ASSESS BODY COMPOSITION IN NORMAL AND OBESE WOMEN. 18 indexed citations
6.
Dale, R.G., et al.. (2001). 22 Allowance for the radiobiological effects of dose gradients in gynaecological applications. Radiotherapy and Oncology. 60. S7–S7. 3 indexed citations
7.
Dale, R.G. & Bleddyn Jones. (1999). Enhanced normal tissue doses caused by tumour shrinkage during brachytherapy.. British Journal of Radiology. 72(857). 499–501. 8 indexed citations
8.
Epstein, Richard J., I. W. F. Hanham, & R.G. Dale. (1997). Radiotherapy-induced second cancers: Are we doing enough to protect young patients?. European Journal of Cancer. 33(4). 526–530. 51 indexed citations
9.
Epstein, Richard J., Steve Kelly, Michael B. Cook, et al.. (1996). Active minimisation of radiation scatter during breast radiotherapy: management implications for young patients with good-prognosis primary neoplasms. Radiotherapy and Oncology. 40(1). 69–74. 21 indexed citations
10.
Boden, R, et al.. (1993). Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model. British Journal of Cancer. 68(1). 69–73. 53 indexed citations
11.
Barnatan, Marcos F., et al.. (1993). The coexistence of Crohn's disease and a nongastrointestinal carcinoid tumor.. PubMed. 88(7). 1120–1. 2 indexed citations
12.
Begent, RHJ, JA Ledermann, K D Bagshawe, et al.. (1989). Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer. British Journal of Cancer. 60(3). 406–412. 50 indexed citations
13.
Ledermann, JA, et al.. (1988). Repeated antitumour antibody therapy in man with suppression of the host response by cyclosporin A. British Journal of Cancer. 58(5). 654–657. 65 indexed citations
14.
Beǵent, Richard H. J., K. D. Bagshawe, RB Pedley, et al.. (1987). Use of second antibody in radioimmunotherapy.. PubMed. 59–61. 24 indexed citations
15.
Pedley, RB, et al.. (1985). A MODEL FOR DOSIMETRY IN RADIOIMMUNOTHERAPY. UCL Discovery (University College London). 2 indexed citations
16.
Dale, R.G.. (1978). Implementation of the Philips treatment planning system for use in radiation teletherapy. British Journal of Radiology. 51(608). 613–621. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026